Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Debt / NOTE 2.000% 8/1
-
Number of holders
-
31
-
Total principal
-
344M
-
Principal change
-
+3.98M
-
Total reported value, excl. options
-
$228M
-
Value change
-
+$1.25M
-
Number of buys
-
11
-
Number of sells
-
-12
-
Price
-
$0.66
Significant Holders of AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1 as of Q4 2015
30 filings reported holding 00767EAB8 - AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1 as of Q4 2015.
AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1 has 31 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $344M of principal
.
Largest 10 bondholders include HIGHBRIDGE CAPITAL MANAGEMENT LLC ($50.5M of principal), HIGHBRIDGE CAPITAL MANAGEMENT LLC ($50.5M of principal), AMERIPRISE FINANCIAL INC ($30.5M of principal), Allianz Asset Management AG ($28.7M of principal), BAKER BROS. ADVISORS LP ($26.5M of principal), UBS OCONNOR LLC ($26M of principal), WOLVERINE ASSET MANAGEMENT LLC ($25.9M of principal), ZAZOVE ASSOCIATES LLC ($15.1M of principal), Tekla Capital Management LLC ($13M of principal), and CITADEL ADVISORS LLC ($11.5M of principal).
This table shows the top 31 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.